Author:
Afrane Adwoa K. A.,Goka Bamenla Q.,Renner Lorna,Yawson Alfred E.,Alhassan Yakubu,Owiafe Seth N.,Agyeman Seth,Sagoe Kwamena W. C.,Kwara Awewura
Abstract
Abstract
Background
Children living with human immunodeficiency virus (HIV) infection require lifelong effective antiretroviral therapy (ART). The goal of ART in HIV-infected persons is sustained viral suppression. There is limited information on virological non-suppression or failure and its associated factors in children in resource limited countries, particularly Ghana.
Methods
A cross-sectional study of 250 children aged 8 months to 15 years who had been on ART for at least 6 months attending the Paediatric HIV clinic at Korle Bu Teaching hospital in Ghana was performed. Socio-demographic, clinical, laboratory and ART Adherence related data were collected using questionnaires as well as medical records review. Blood samples were obtained for viral load and CD4+ count determination. Viral load levels > 1000 copies/ml on ART was considered virological non-suppression. Logistic regression was used to identify factors associated with virological non-suppression.
Results
The mean (±SD) age of the study participants was 11.4 ± 2.4 years and the proportion of males was 53.2%. Of the 250 study participants, 96 (38.4%) had virological non-suppression. After adjustment for significant variables, the factors associated with non-suppressed viral load were female gender (AOR 2.51 [95% CI 1.04–6.07], p = 0.041), having a previous history of treatment of tuberculosis (AOR 4.95 [95% CI 1.58–15.5], p = 0.006), severe CD4 immune suppression status at study recruitment (AOR 24.93 [95% CI 4.92–126.31], p < 0.001) and being on a nevirapine (NVP) based regimen (AOR 7.93 [95% CI 1.58–1.15], p = 0.005).
Conclusion
The prevelance of virological non-suppression was high. Virological non-suppression was associated with a previous history of TB treatment, female gender, severe CD4 immune suppression status at study recruitment and being on a NVP based regimen. Early initiation of ART and phasing out NVP-based regimen might improve viral load suppression in children. In addition, children with a history of TB may need focused measures to maximize virological suppression.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. History of HIV and AIDS overview | Avert. https://www.avert.org/professionals/history-hiv-aids/overview (Accessed 26 Dec 2019).
2. HIV/AIDS Facts, Prevention, Signs, Symptoms & Medications. eMedicineHealth. https://www.emedicinehealth.com/hivaids/article_em.htm (Accessed 26 Dec 2019).
3. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7(1):13. https://doi.org/10.1186/1471-2431-7-13.
4. Aids C on P, Health S on IC. Increasing antiretroviral drug access for children with HIV infection. Pediatrics. 2007;119(4):838–45. https://doi.org/10.1542/peds.2007-0273.
5. WHO | Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. WHO. http://www.who.int/hiv/pub/guidelines/keypopulations-2016/en/ (Accessed 20 Sep 2016).